Does the diagnosis of primary biliary cirrhosis of autoimmune cholangitis depend on the 'phase' of the disease?

Liver International

Volumn 25, Issue 2, 2005, Pages 317-324

  Kadokawa, Yoshiko ^a   Omagari, Katsuhisa ^a   Ohba, Kazuo ^a   Masuda, Jun Ichi ^a   Hazama, Hiroaki ^a   Kinoshita, Hideki ^a   Ohnita, Ken ^a   Mizuta, Yohei ^a   Tanioka, Hajime ^b   Imanishi, Takeo ^c   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Senju Hospital   (Japan)

^c Koebaru Chuo Hospital   (Japan)

Author keywords

Antimitochondrial antibody; Auto immune cholangitis; Longitudinal study; Primary biliary cirrhosis; Western blotting

Indexed keywords

MITOCHONDRION ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CHOLANGITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; MALE; PRIMARY BILIARY CIRRHOSIS; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; BLOTTING, WESTERN; CHOLANGITIS; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER FUNCTION TESTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MITOCHONDRIA; PROBABILITY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 20144389228     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01078.x     Document Type: Article

References (35)

1. Talwalkar J A, Lindor K D. Primary biliary cirrhosis. Lancet 2003; 362: 53-61.
2. Brunner G, Klinge O. A cholangitis with antinuclear antibodies (immunocholangitis) resembling chronic destructive non-suppurative cholangitis. Dtsch Med Wochenschr 1987; 112: 1454-8.
3. Carrougher J G, Shaffer R T, Canales L I, Goodman Z D. A 33-year-old woman with an autoimmune syndrome. Semin Liver Dis 1991; 11: 256-62.
4. Ben-Ari Z, Dhillon A P, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993; 18: 10-5.
5. Michieletti P, Wanless I R, Katz A, Scheuer P J, Yeaman S J, Bassendine M F, et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 1994; 35: 260-5.
6. Taylor S L, Dean P J, Riely C A. Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol 1994; 18: 91-9.
7. Lacerda M A, Ludwig J, Dickson E R, Jorgensen R A, Lindor K D. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 1995; 90: 247-9.
8. Goodman Z D, Mcnally P R, Davis D R, Ishak K G. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 1995; 40: 1232-42.
9. Omagari K, Ikuno N, Matsuo I, Shirono K, Hara K, Feeney S J, et al. Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis. Pathology 1996; 28: 255-8.
10. Heathcote J. Autoimmune cholangitis. Gut 1997; 40:440-2.
11. Sherlock S. Autoimmune cholangitis: a unique entity? Mayo Clin Proc 1998; 73: 184-90.
12. Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi, Sugi K, et al. Autoimmune cholangitis and primary biliary cirrhosis - an autoimmune enigma. Liver 1999; 19: 122-8.
13. Muratori P, Muratori L, Gershwin M E, Czaja A J, Pappas G, Maccariello S, et al. 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol 2004; 135: 154-8.
14. Masuda J, Omagari K, Matsuo I, Kinoshita H, Sakimura K, Hazama H, et al. Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirhosis. J Gastroenterol Hepatol 2001; 16: 239-43.
15. Cho Y J, Han D S, Kim T Y, Jang S J, Jeon Y C, Sohn J H, et al. Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis. J Korean Med Sci 1999; 14: 102-6.
16. Kaplan M M. Primary biliary cirrhosis. N Engl J Med 1996; 335: 1570-80.
17. Alvarez F, Berg P A, Bianchi F B, Bianchi L, Burroughs A K, Canacado E L, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-38.
18. Omagari K, Kadokawa Y, Ishihara Y, Kohno S. Clinical significance of antimitochondrial antibody by ELISA using 'MESACUP-2 Test Mitochondrial M2' kit for the diagnosis of primary biliary cirrhosis. Jpn J Med Pharm Sci 2003; 50: 543-50 (in Japanese).
19. Kadokawa Y, Omagari K, Hazama H, Ohba K, Masuda J, Kinoshita H, et al. Evaluation of newly developed ELISA using 'MESACUP-2 Test Mitochondrial M2' kit for the diagnosis of primary biliary cirrhosis. Clin Biochem 2003; 36: 203-10.
20. Takemura M, Ohya K, Kojima K. Fundamental evaluation of 'MESACUP-2 Test Mitochondrial M2. Jpn J Med Pharm Sci 2001; 46: 809-16 (in Japanese).
21. Stanley C J, Perham R N. Purification of 2-oxo-acid dehydrogenase multienzyme complexes from ox heart by a new method. Biochem J 1980; 191: 147-54.
22. Kinoshita H, Omagari K, Matsuo I, Yamaguchi K, Ikuno N, Kohno S. Frequency of IgG, IgM, and IgA class autoantibodies against 2-oxo-acid dehydrogenase complex in 102 Japanese patients with primary biliary cirrhosis. Hepatol Res 1999; 15: 163-71.
23. Scheuer P J, Lefkowitch J H Biliary disease. In: Scheuer PJ, Lefkowitch JH, eds. Liver Biopsy Interpretation, 6th edn. London: WB.Saunders Co., 2000; 66-91.
24. Vierling J M. Primary biliary cirrhosis and autoimmune cholangiopathy. Clin Liver Dis 2004; 8: 177-94.
25. Ikuno N, Scealy M, Davies J M, Whittingham S F, Omagari K, Mackay I R, et al. A comparative study of antibody expressions in primary biliary cirrhosis and autoimmune cholangitis using phage display. Hepatology 2001; 34: 478-86.
26. Tanaka A, Miyakawa H, Luketic V A C, Kaplan M, Storch W B, Gershwin M E. The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis. Cell Mol 2002; 48: 295-9.
27. Ishibashi H. Are primary biliary cirrhosis and autoimmune cholangitis reflective of the pendulum of a clock and therefore represent a 'phase' of the same disease? J Gastroenterol Hepatol 2001; 16: 121-3.
28. Neuberger J, Thomson R. PBC and AMA - what is the connection? Hepatology 1999; 29: 271-6.
29. Poupon R E, Balkau B, Eschwege E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 1991; 324: 1548-54.
30. Turner I B, Myszor M, Mitchison H C, Bennett M K, Burt A D, James O F. A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis. J Gastroenterol Hepatol 1994; 9: 162-8.
31. Teoh K -L, Rowley M J, Zafirakis H, Dickson E R, Weisner R H, Gershwin M E, et al. Enzyme inhibitory autoantibodies to pyruvate dehydrogenase complex in primary biliary cirrhosis: applications of a semiautomated assay. Hepatology 1994; 20: 1220-4.
32. Kisand K E, Karvonen A-L, Vuoristo M, Farkkila M, Lehtola J, Inkovaara J, et al. Ursodeoxycholic acid treatment lowers the serum level of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis. J Mol Med 1996; 74: 269-74.
33. Miyakawa H, Kawaguchi N, Abe K, Kitazawa E, Kikuchi K, Fujikawa H, et al. Serial changes of serum anti-M2 proteins in patients with primary biliary cirrhosis: a follow-up study by immunoblotting. Hepatol Res 1999; 13: 143-52.
34. Hazama H, Omagari K, Masuda J, Kinoshita H, Ohba K, Sakimura K, et al. Serial changes in enzyme inhibitory antibody to pyruvate dehydrogenase complex during the course of primary biliary cirrhosis. J Clin Lab Anal 2000; 14: 208-13.
35. Benson G D, Kikuchi K, Miyakawa H, Tanaka A, Watnik M R, Gershwin M E. Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis. Clin Dev Immunol 2004; 11: 129-33.